Chinook Therapeutics, Inc. Stock
Equities
KDNY
US16961L1061
Biotechnology & Medical Research
Latest transcript on Chinook Therapeutics, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Noopur Liffick
IRC | Investor Relations Contact | - | 20-09-30 |
Valerie Fauvelle
LAW | General Counsel | - | - |
Sukhi Thethy
AUD | Comptroller/Controller/Auditor | - | - |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.11% | 0 M€ | 0.00% | - | |
0.09% | 0 M€ | 0.00% | - | |
0.03% | 237 M€ | +1.04% | - |
1st Jan change | Capi. | |
---|---|---|
-2.26% | 103B | |
+1.41% | 95.71B | |
+0.76% | 22.02B | |
-17.84% | 20.9B | |
-9.00% | 17.85B | |
-42.83% | 16.21B | |
-17.63% | 15.52B | |
+4.55% | 13.86B | |
+32.11% | 12.04B |